Patent ID: 11903912
Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. The method of claim 1, wherein selenopsammaplin A or a derivative thereof represented by Formula 1 is selected from the group consisting of:
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(3-bromo-4-hydroxyphenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(3-chloro-4-hydroxyphenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(3-fluoro-4-hydroxyphenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(2-(hydroxyimino)-3-phenylpropanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(4-fluorophenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(4-chlorophenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(4-bromophenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(3,4-difluorophenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3,4-dichlorophenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(4-ethoxyphenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(4-benzyloxy)phenyl)-2-(hydroxyimino)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(2-(hydroxyimino)-3-(4-nitrophenyl)propanamide);
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(3-(4-tert-butyl)phenyl)-2-(hydroxyimino)propanamide); and
(2E,2′E)-N,N′(diselenediylbis(ethane-2,1-diyl))bis(2-(hydroxyimino)-3-(naphthalene-2-yl)propanamide).